Search

Your search keyword '"Monforte AD"' showing total 300 results

Search Constraints

Start Over You searched for: Author "Monforte AD" Remove constraint Author: "Monforte AD"
300 results on '"Monforte AD"'

Search Results

1. Mapping the human genetic architecture of COVID-19

2. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period

3. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV

4. The EuroSIDA study: 25 years of scientific achievements

5. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

6. ANALYSIS OF IMPEDIMENTS TO THE MAINTENANCE IN CARE OF PEOPLE WITH HIV IN ITALY

7. Evaluation of Protective Genetic Variants in HIV-1-infected cART Treated Patients

8. Effectiveness and safety of cobicistat-boosted darunavir-based antiretroviral treatment in an Italian observational cohort: the TMC114FD1HTX4003 (STORE.) study

9. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy

10. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

11. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

12. Effect of incident hepatitis C infection on CD4(+) cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort

13. Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

14. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

16. Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

18. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

19. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study

20. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

22. Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

23. Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort

24. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016

25. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011

26. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

27. Combination antiretroviral therapy and the risk of myocardial infarction

28. Role of Microbial Translocation (MT) and Immune Hyperactivation (IH) in Liver Disease Progression of HIV/HCV plus Patients with well documented HIV seroconversion date and preserved CD4 count

29. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

30. Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

31. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

32. Long-term Mortality in HIV-Positive Individuals Virally Suppressed for > 3 Years With Incomplete CD4 Recovery

33. Impact of Coinfection With HIV-1 and GB Virus C in Patients Receiving a Ritonavir-Boosted HAART Regimen: A Substudy to the MaxCmin1 Trial

34. Diagnosis of Virus-associated Opportunistic Diseases of the Central Nervous System in Patients with HIV Infection by Polymerase Chain Reaction on Cerebrospinal Fluid

35. Risk of tuberculosis following HIV seroconversion in high-income countries

36. Natural history of HIV-control since seroconversion

37. Inconsistent condom use among HIV-positive women in the ‘‘Treatment as Prevention Era’’: data from the Italian DIDI study

38. Italian HIV GuidelinesWorking Group. Italian guidelines for the use of antiretroviral agents and thediagnostic-clinical management of HIV-1 infected persons. Update 2011

39. Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe

40. Prevalence of prolonged amenorrhea in HIV-infected women. Results from the Italian DIDI study

41. Risk of triple-class virological failure in children with HIV: a retrospective cohort study

42. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

43. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

44. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change

45. Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study

46. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

47. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

48. Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice

49. Response to combination antiretroviral therapy: Variation by age

50. Genetic polymorphisms differently influencing the emergence of atrophy and fataccumulation in HIV-related lipodystrophy

Catalog

Books, media, physical & digital resources